Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.
Company Details
- Employees
- 18
- Address
- 100 Technology Sq,
- Phone
- (617) 914 8420
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- avrobio.com
- Keywords
- Gene Therapy and Rare Disease.
- HQ
- Cambridge, Massachusetts
Avrobio Questions
Avrobio's helpline number is (617) 914 8420
Avrobio's website is avrobio.com
Avrobio's LinkedIn profile is https://www.linkedin.com/company/avrobio
Avrobio has
18 employees.
View email and phone details for 18
employees at Avrobio.
Avrobio's industry is
Biotechnology Research
Avrobio's top competitors are
Laboratorios Ecar,
Northern Rna Inc.,
Providence Therapeutics,
Lifefactors,
Vaxthera,
Tectonic Therapeutic, Inc.,
Southern Rna 🧬,
Bioingred Tech,
Bluerock Therapeutics,
Bialtec.
Avrobio's support email address is info@avrobio.com
Avrobio's categories are Biotechnology Research
